With Duster-based Nissan SUV and Triber-based 7-seater MPV, the company aims to have four vehicles in its portfolio by FY26 ...

Two oral presentations will highlight the continued potent antiviral activity of ALG-000184 for chronic hepatitis B virus (HBV) infection in both HBeAg-positive and HBeAg-negative subjects, ...

VESPER-2 is a 28-week Phase 2b clinical trial assessing the efficacy and tolerability of different weekly doses of MET-097i with or without titration. The trial enrolled the first participant in March ...

The upcoming Volkswagen Tiguan R-Line for India is confirmed to get the 2.0-litre turbo petrol engine and will be available ...

IM Presented by MG Motor isn't a name that rolls off the tongue, but this premium EV specialist is rolling into local ...

Argenx is a hold due to limited catalysts in 2025, a rich valuation and clinical risk around label expansion. Read more about ...

Samman, A. and Babi, A. (2025) Pulmonary Septic Emboli Following Endocarditis: A Case Report. Open Journal of Clinical ...

KARACHI: The prices of different makes and models of cars prevailing in Karachi in the week ended Sunday (March ...

A dissolvable oral dispersible film of dolutegravir could transform treatment ANALYSIS | MELODY CHIRONDA | In the fight ...

"The launch of ZUNVEYL is a game-changer in our fight against Alzheimer’s disease," said Lauren D’Angelo, COO and chief ...

Genmab A/S(Nasdaq: GMAB) announced today updated data from cohort B1 of the Phase 1/2 RAINFOL-01 study of rinatabart sesutecan (Rina-S ® ), an investigational folate receptor-alpha (FRα)-targeted, ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.